Log In
No results found for "".

Deal Details

C/PIndustryStatusTicker(s)Issuer(s)Size(m)TranchesRegionDate
HYC
HLTH
PRCD
PHARGR
Phoenix PIB Dutch Finance BV€500
1EMEA
Jul 3, 2024
currency
EUR
size (m)
500.000
maturity
Jul 10, 2029
type
Fixed
tenor
5.000
call
0.00
registration
Reg S Only
benchmark
-
ranking
Sr. Unsecured
moody's
NR
s&p
BB+
fitch
-
size description
-
re-open/tap
No
ipt
5.375-5.50%
ipt-pxd
-
guidance
5.125% area (+/- 0.125%)
spread
247.4
coupon
4.875%
spread set
-
price
99.45900
yield
5.000%
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
joint leads
passive leads
-
co-managers
-
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
joint leads
passive leads
-
co-managers
-
coordinating managers
-
Tranche Comments
Registration: Reg S Only; Comments: B&D: DEU;
Deal Comments
07/03/2024 PHOENIX PIB Dutch Finance BV (PHARGR) EUR500m (from EUR400-500m) Reg S sr unsec notes due 07/10/29 (5y). NCL (MWC B+40bp) (3m par call) (85% clean-up call). NR/BB+ (--/stable). Via Barc/BofA/DB (B&D)/ING/LBBW/SEB jt glocos and books. List Lux. German law. CoC. Settles 07/10. ISIN: XS2856820704. IPT: 5.375%-5.50%. Guidance: 5.125% area (+/- 0.125%). Final terms: EUR500 at 5.00% yield. Priced: 4.875% at 99.459, yield 5.00%. +247.4bp vs DBR 0.25% 02/15/29. ms+209.4bp. Investor calls started 07/01. Books closed at 1pm UKT 07/03. Books over EUR2bn. UOP: GCP, repayment of existing debt, including the tender offer for its EUR400m 2.375% fixed rate bearer notes due 08/05/25 (ISIN: XS2212959352), repurchase price 98.35, expires 5pm CEST 07/09/24, Barc/BofA/DB/ING/LBBW/SEB dealer managers. Biz: a leading integrated healthcare provider in Europe operating in Pharmaceutical Wholesale, Pharmaceutical Retail and Pharma Services. HQ: Marassen, The Netherlands/Mannheim, Germany. Investor Presentation:http://www.netroadshow.com/nrs/home/#!/?show=929acbfe| Entry Code: Adelphi2024 (not case-sensitive)

Commentary

Explore all other Commentary & Deal Flow

Deal Flow

Explore all other Commentary & Deal Flow